Abstract:The emergence of multidrug-resistant bacteria has dramatically increased the lethality, level of resistance, and difficulty of treatment. In this study, a series of new antimicrobial peptides (AMPs) based on the β-hairpin structure with the template (XY) 2 RRRF(YX) 2 -NH 2 (X: hydrophobic amino acids; Y: cationic amino acids) were synthesized; surprisingly, almost all of the new peptides have strong antibacterial activity and negligible hemolytic toxicity. Particularly, the therapeutic index (TI) values of F(R… Show more
“…Also, the more hydrophobic peptides induced higher PI fluorescence intensity than the less hydrophobic peptides (AS4-1 < AS4-5 < AS4-9) (Figure D). The AMP-induced bacterial membrane permeabilization generally results in continuous fluorescent dye transmembrane translocation for a long time even after bacterial cell death. , In the present study, although AS4-1, AS4-5, and AS4-9 needed less than 120 min to kill the bacterial cells in killing kinetics assay (Figure A), we can find that the calcein and PI fluorescence intensity induced by them continuously increased with the time extension to 180 min. All the results above prove that hydrophobicity, rather than net charge, is the key structural parameter for α-helical AMPs to permeabilize the bacterial IM and lead to the subsequent cell lysis.…”
Rapid antimicrobial action is an important advantage of antimicrobial peptides (AMPs) over antibiotics, which is also a reason for AMPs being less likely to induce bacterial resistance. However, the structural parameters and underlying mechanisms affecting the bacterial killing rate of AMPs remain unknown. In this study, we performed a structure−activity relationship (SAR) study using As-CATH4 and 5 as templates. We revealed that hydrophobicity, rather than other characteristics, is the critical structural parameter determining the bacterial killing rate of α-helical AMPs. With the hydrophobicity increase, the action rates of AMPs including bacterial binding, lipopolysaccharides neutralization, and outer and inner membrane permeabilization increased. Additionally, the higher hydrophobic AMPs with enhanced bacterial killing rates possess better in vivo therapeutic potency and a lower propensity to induce bacterial resistance. These findings revealed the importance of the bacterial killing rate for AMPs and are of great significance to the design and optimization of AMP-related drugs.
“…Also, the more hydrophobic peptides induced higher PI fluorescence intensity than the less hydrophobic peptides (AS4-1 < AS4-5 < AS4-9) (Figure D). The AMP-induced bacterial membrane permeabilization generally results in continuous fluorescent dye transmembrane translocation for a long time even after bacterial cell death. , In the present study, although AS4-1, AS4-5, and AS4-9 needed less than 120 min to kill the bacterial cells in killing kinetics assay (Figure A), we can find that the calcein and PI fluorescence intensity induced by them continuously increased with the time extension to 180 min. All the results above prove that hydrophobicity, rather than net charge, is the key structural parameter for α-helical AMPs to permeabilize the bacterial IM and lead to the subsequent cell lysis.…”
Rapid antimicrobial action is an important advantage of antimicrobial peptides (AMPs) over antibiotics, which is also a reason for AMPs being less likely to induce bacterial resistance. However, the structural parameters and underlying mechanisms affecting the bacterial killing rate of AMPs remain unknown. In this study, we performed a structure−activity relationship (SAR) study using As-CATH4 and 5 as templates. We revealed that hydrophobicity, rather than other characteristics, is the critical structural parameter determining the bacterial killing rate of α-helical AMPs. With the hydrophobicity increase, the action rates of AMPs including bacterial binding, lipopolysaccharides neutralization, and outer and inner membrane permeabilization increased. Additionally, the higher hydrophobic AMPs with enhanced bacterial killing rates possess better in vivo therapeutic potency and a lower propensity to induce bacterial resistance. These findings revealed the importance of the bacterial killing rate for AMPs and are of great significance to the design and optimization of AMP-related drugs.
“…The results demonstrated that GHb3K and GHbK4R not only have good antibacterial activity in vitro but also show better therapeutic efficacy than vancomycin in acute pneumonia in vivo. It was reported that F(RI)2R and F(KW)2K exhibited anti-infection effects in a mouse model of pulmonary infections by S. aureus . Although F(RI)2R and F(KW)2K showed remarkable efficacy in vivo, they were toxic to the lung and liver.…”
Section: Discussionmentioning
confidence: 99%
“…It was reported that F(RI)2R and F(KW)2K exhibited anti-infection effects in a mouse model of pulmonary infections by S. aureus. 44 Although F(RI)2R and F(KW)2K showed remarkable efficacy in vivo, they were toxic to the lung and liver. In comparison, GHb3K and GHbK4R exhibited superior bactericidal properties, low toxicity, and high stability.…”
Section: Acs Infectious Diseasesmentioning
confidence: 99%
“…The peptides were dissolved in deionized water, 50% TFE (mimicking the hydrophobic environment of microbial membrane), and 30 mM SDS (mimicking the negatively charged prokaryotic membrane) at a concentration of 0.4 mg/mL. 44 The peptide solution was added into a quartz cuvette with 0.1 cm path lengths. The spectrum was monitored by using a Chirascan spectropolarimeter (Applied Photophysics, Leatherhead, UK) from 190 to 250 nm.…”
With the continuous development of drug resistance in
bacteria
to traditional antibiotics, the demand for novel antibacterial agents
is urgent. Antimicrobial peptides (AMPs) are promising candidates
because of their unique mechanism of action and low tendency to induce
drug resistance. Previously, we cloned temporin-GHb (hereafter referred
to simply as “GHb”) from Hylarana guentheri. In this study, a series of derived peptides were designed, namely,
GHbR, GHbK, GHb3K, GHb11K, and GHbK4R. The five derived peptides had
stronger antibacterial activities against Staphylococcus aureus than the parent peptide GHb and could effectively inhibit the formation
of biofilms and eradicate mature biofilms in vitro. GHbR, GHbK, GHb3K,
and GHbK4R exerted bactericidal effects by disrupting membrane integrity.
However, GHb11K exhibited bacteriostatic efficacy with toroidal pore
formation on the cell membrane. In comparison to GHbK4R, GHb3K showed
much lower cytotoxicity against A549 alveolar epithelial cells, with
an IC50 > 200 μM, which was much higher than its
minimal inhibitory concentration (MIC = 3.1 μM) against S. aureus. The anti-infection potential of GHbK4R and GHb3K
was investigated in vivo. Compared with vancomycin, the two peptides
displayed significant efficacy in a mouse model of acute pneumonia
infected with S. aureus. Both GHbK4R and GHb3K also
had no obvious toxicity to normal mice after intraperitoneal administration
(15 mg/kg) for 8 days. Our results indicate that GHb3K and GHbK4R
might be promising candidates for the treatment of bacterial pneumonia
infected with S. aureus.
“…Membrane disruptive antimicrobial peptides (AMPs), which occur naturally as part of the innate immune system, offer an opportunity to address multidrug-resistant (MDR) bacteria because of their unspecific mechanism of action, against which resistance does not occur easily. − Such AMPs are however unstable in serum and most often toxic owing to their membrane disruptive amphiphilic and usually α-helical structure triggering their antibacterial effect. Their properties can be improved by sequence optimization, − whereby the most versatile approach consists in introducing non-natural structural elements such as d -amino acids, − non-natural residues, β- or γ-amino acids, , isopeptide bonds, or entirely non-peptidic elements such as spermine or fatty acids. , A complete redesign of AMPs is also possible in the form of dimers, cyclic or bicyclic staples, − small molecules, peptoids, , foldamers, or dendrimers. , …”
Membrane disruptive α-helical antimicrobial peptides (AMPs) offer an opportunity to address multidrug resistance; however, most AMPs are toxic and unstable in serum. These limitations can be partly overcome by introducing D-residues, which often confers protease resistance and reduces toxicity without affecting antibacterial activity, presumably due to lowered α-helicity. Here, we investigated 31 diastereomers of the α-helical AMP KKLLKLLKLLL. Three diastereomers containing two, three, and four D-residues showed increased antibacterial effects, comparable hemolysis, reduced toxicity against HEK293 cells, and excellent serum stability, while another diastereomer with four D-residues additionally displayed lower hemolysis. X-ray crystallography confirmed that high or low α-helicity as measured by circular dichroism indicated α-helical or disordered structures independently of the number of chirality switched residues. In contrast to previous reports, α-helicity across diastereomers correlated with both antibacterial activity and hemolysis and revealed a complex relationship between stereochemistry, activity, and toxicity, highlighting the potential of diastereomers for property optimization.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.